Please login to the form below
KOL Strategy
This page shows the latest KOL Strategy news and features for those working in and with pharma, biotech and healthcare.
New accounts: September
Aranesp KOL strategy. Oncology. central. Amgen European HQ. Mimpara meetings. Nephrology. ... central. Amgen European HQ. Neulasta KOL strategy. Oncology. central. Baxter Healthcare UK.
Latest news
-
New accounts: October
Amgen European HQ. Aranesp KOL strategy. Oncology. central. Amgen European HQ. ... Mimpara meetings. Nephrology. central. Amgen European HQ. Neulasta KOL strategy. Oncology.
-
New accounts: November
Allergan. Botox. Neurology. Jango Communications. Amgen European HQ. Aranesp KOL strategy. ... Neulasta KOL strategy. Oncology. central. GlaxoSmithKline. Cervarix. Cervical cancer (consumer healthcare).
More from news
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients
Sandra Graham-Mason, Director of Marketing at Regeneron Pharmaceuticals discusses a variety of topics, from the impact of COVID-19 on the way that Pharma teams interact with internal stakeholders and KOLs to the challenges it has brought for
-
emotive. expands Medical Writing and Client Services teams
She brings a breadth of knowledge in pre-launch strategy and tactical implementation, KOL development, patient engagement, disease awareness and CME programmes, working with both marketing and medical clients.
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Digital account director
-
Competitive
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
- Client Services Director +, Remote or London – Leadership Opport...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
-
Digital strategist
-
Competitive
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
-
Digital project manager
-
Competitive
- FREELANCE (Outside IR35) Opportunities for this week below!!!
-
Superb Day Rate
- Israel study suggests Pfizer/BioNTech vaccine is less effective against Delta variant
- Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy
- GSK reveals plans for £400m R&D facility expansion in England
- FDA advisory committee votes against approval of AZ, FibroGen's roxadustat
- Novartis highlights potential of its radioligand therapy in prostate cancer at ASCO
- bluebird bio to restart marketing of Zynteglo in EU after previous suspension
- Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader
- Roche engaged in talks with FDA for Alzheimer’s drug candidate
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- The future of work has been just around the corner for some time...
- Investigating the Complexities of the Canadian & Global Health Systems
- Impetus Digital Overview
- FDA advisory committee votes against approval of AZ, FibroGen's roxadustat
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Roche engaged in talks with FDA for Alzheimer’s drug candidate
- Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader
- British officials reportedly monitoring Philip Morris’ proposed acquisition of Vectura
- Keytruda scores a win in treating early-stage breast cancer pre- and post-surgery
PMHub
Dovetail
We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...
Latest intelligence
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
- The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
- Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
- Virtual Speaker Program: A Customer Story
- Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....
